Evaluation of Cytokine Biomarkers in Melanoma Patients During Immunotherapy
Status:
Recruiting
Trial end date:
2023-03-25
Target enrollment:
Participant gender:
Summary
Open prospective clinical trial to develop the computer software (Intelligent prognostic
system) for predicting the efficacy of anti-PD-1 immunotherapy of melanoma patients in
routine practice